Covaxin, the vaccine candidate developed by Bharat Biotech India Limited (BBIL) in collaboration with Indian Council of Medical Research (ICMR), has received approvals from India’s drug control authority, Drugs Controller General of India (DCGI's) Expert Committee for the initiation of the final and Phase III clinical trials.

Bharat Biotech's Covaxin receives approval for Phase III trials: Reports

After Russia, these COVID-19 vaccines set to unveil soon!

India's first coronavirus vaccine 'COVAXIN' human trials will begin on July 21 at the All India Institute of Medical Science (AIIMS), Delhi after its Ethics Committee gave its nod. COVAXIN is an indigenously developed COVID-19 vaccine. Watch report.

'Covaxin' human trial begins in AIIMS: Phase 1 & 2 trials of potential vaccine